Indirect spectrophotometric determination of diltiazem hydrochloride in pure form and pharmaceutical formulations

• Authors: Akram El-Didamony
• Languages of publication: EN

Abstracts

EN

Three simple, accurate, and sensitive spectrophotometric methods (A, B and C) have been described for the indirect assay of diltiazem hydrochloride (DIL.HCl), either in pure form or in pharmaceutical formulations. The first method (A) is based on the oxidation of DIL.HCl by N-bromosuccinimide (NBS) and determination of unconsumed NBS by measuring the decrease in absorbance of amaranth dye (AM) at a suitable λmax=521 nm. Other methods (B) and (C) involve the addition of excess cerric ammonium sulfate (CAS) and subsequent determination of the unconsumed oxidant by a decrease in the red color of chromotrope 2R (C2R) at a suitable λmax=528 nm or a decrease in the orange-pink color of rhodamine 6G (Rh6G) at λmax=525 nm, respectively. Regression analysis of Beer-Lambert plots showed good correlation in the concentration ranges 3.0–9.0, 3.5–7.0 and 3.5–6.3 μg ml−1 for methods A, B and C, respectively. The apparent molar absorptivity, Sandell's sensitivity, detection and quantification limits were calculated. The proposed methods have been applied successfully for the analysis of the drug in its pure form and its dosage form. No interference was observed from a common pharmaceutical adjuvant. Statistical comparison of the results with the reference method shows excellent agreement and indicates no significant difference in accuracy and precision.

Keywords

EN

spectrophotometry; Diltiazem HCl; oxidation reaction; N-bromosuccinimide; cerric ammonium sulfate; pharmaceutical formulations

• Publisher: De Gruyter Open
• Journal: Open Chemistry
• Year: 2005
• Volume: 3
• Issue: 3
• Pages: 520-536

Dates

published

1 - 9 - 2005

online

1 - 9 - 2005

Contributors

author

Akram El-Didamony

• Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, Egypt

References

• [1] C.A. Fisher, M.F. Josephson, Y.T. Wacht-Fogel, R.W. Coleman and V.P. Addonizio: “Verapamil and diltiazem as antiplatelet agents, spectrum and mechanisms of activity”, Circulation, Vol. 68, (1983), pp. 318.
• [2] T. Funyu, K. Nigawara, K. Ohno, W. Hamada and Y. Yagihashi: “Effects of benzothiazepine derivative on blood pressure, excretion of electrolytes and plasma rennin activities”, Clin. Ther., Vol. 3, (1981), pp. 456–466.
• [3] British Pharmacopoeia, Vol. I, Her Majestys Stationary Office, London, 1998.
• [4] The United States Pharmacopoeia, The United States Pharmacopoeia Convention, 22nd ed., Rockville, 1990.
• [5] V. Rovel, M. Miltchard and P.L. Morselli: “Simple, sensitive and specific gas chromatographic method for the quantification of diltiazem in human body fluids”, J. Chromatogr., Vol. 138, (1977), pp. 391–398. http://dx.doi.org/10.1016/S0021-9673(00)94974-4[Crossref]
• [6] J.P. Clozel, G. Caille, Y. Taeymans, P. Theroux, P. Biron and J.G Besner: “Improved gas chromatographic determination of diltiazem and deacetyldiltiazem in human plasma”, J. Pharm. Sci., Vol. 73, (1984), pp. 207–209. http://dx.doi.org/10.1002/jps.2600730616[Crossref]
• [7] O. Grech-Belanger, E. Leboeuf and S. Langlois: “Assay of diltiazem and deacetyldiltiazem by capillary gas chromatography”, J. Chromatogr., Vol. 417, (1987), pp. 89–98.
• [8] Y. Kuwahara and H. Nishi: “Fast drug analysis by capillary electrophoresis, content uniformity and assay for diltiazem tablets and trimetoquinol tablets”, Yakugaku Zasshi, Vol. 118, (1998), pp. 456–463.
• [9] G.J. Vergote, C. Vervaet, J.P. Remon, T. Haemers and F. Verpoort: “Near-infrared FT-Raman spectroscopy as a rapid analytical tool for the determination of diltiazem hydrochloride in tablets”, Eur. J. Pharm. Sci., Vol. 16, (2002), pp. 63–67. http://dx.doi.org/10.1016/S0928-0987(02)00058-1[Crossref]
• [10] J. Wang, P.A. Farias and J.S. Mahmoud: “Measurements of low concentrations of diltiazem by adsorptive stripping voltammetry and flow amperometry”, Analyst, Vol. 111, (1986), pp. 837–839. http://dx.doi.org/10.1039/an9861100837[Crossref]
• [11] R.E. Wiens, D.J. Runser, J.P. Lacz and D.C. Dimmitt: “Quantitation of diltiazem and desacetyldiltiazem in dog plasma by high-performance liquid chromatography”, J. Pharm. Sci., Vol. 73, (1984), pp. 688–699. http://dx.doi.org/10.1002/jps.2600730525[Crossref]
• [12] J.P. Clozel, G. Caille, Y. Toeymans, P. Theroux, P. Biron and F. Trudel: “High-performance liquid chromatographic determination of diltiazem and six of its metabolites in human urine”, J. Pharm. Sci., Vol. 73, (1984), pp. 771–773. http://dx.doi.org/10.1002/jps.2600730616[Crossref]
• [13] D.R. Abernethy, J.B. Schwartz and E.L. Todd: “Diltiazem and desacetyldiltiazem analysis in human plasma using high-performance liquid chromatography: improved sensitivity without derivation”, J. Chromatogr., Vol. 342, (1985), pp. 216–220.
• [14] L.M. Dube, N. Mousseau and I.J. McGilveray: “High-performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma: evaluation of their stability”, J. Chromatogr., Vol. 430, (1988), pp. 103–111.
• [15] S. Boucher, F. Varin, Y. Theoret, P. Du Souich and G. Caille: “High-performance liquid chromatographic method for the determination of diltiazem and two of its metabolites in human plasma: application to a new sustained release formulation”, J. Pharm. Biomed. Anal., Vol. 7, (1989), pp. 1925–1930. http://dx.doi.org/10.1016/0731-7085(89)80216-X[Crossref]
• [16] P.V. Devarajan and V.V. Dhavse: “High-performance thin-layer chromatographic determination of diltiazem hydrochloride as bulk drug and in pharmaceutical preparations”, J. Chromatogr., B: Biomed. Appl., Vol. 706, (1998), pp. 362–366. http://dx.doi.org/10.1016/S0378-4347(97)00548-3[Crossref]
• [17] P.M. Lacroix, N. Beaulieu, T.D. Cyr and E.G. Lovering: “High-performance liquid chromatography method for assay of diltiazem hydrochloride and its related compounds in bulk drug and finished tablets”, J. Pharm. Sci., Vol. 78, (1989), pp. 243–246. http://dx.doi.org/10.1002/jps.2600780315[Crossref]
• [18] P.M. Lacroix, N. Beaulieu, T.D. Cyr and E.G. Lovering: “High-performance liquid chromatography method for assay of diltiazem hydrochloride and its related compounds in bulk drug and finished tablets”, J. Pharm. Sci., Vol. 78, (1989), pp. 243–246. http://dx.doi.org/10.1002/jps.2600780315[Crossref]
• [19] Y. Shah, S. Khanna, V.S. Dighe and K.C. Jindal: “High-performance liquid chromatographic determination of diltiazem hydrochloride in tablets”, Indian Drugs, Vol. 27, (1990), pp. 363–364.
• [20] R.S. Chaudhary, S.S. Gangwal, M.K. Avachat, Y.N. Shah and K.C. Jindal: “Determination of diltiazem hydrochloride in human serum by high-performance liquid chromatography”, J. Chromatogr., Vol. 614, (1993), pp. 261–266.
• [21] Y.S.R. Krishnaiah and S.S. Patro: “Determination of diltiazem hydrochloride in human plasms by high-performance liquid chromatography”, Indian Drug, Vol. 37, (2000), pp. 570–573.
• [22] B. Chankvetadze, I. Kartozia and G. Blaschke: “Simultaneous enantioseparation of cis- diltiazem hydrochloride and its metabolite cis- desacetyldiltiazem using high-performance liquid chromatography and capillary electrophoresis”, J. Pharm. Biomed. Anal., Vol. 27, (2002), pp. 161–166. http://dx.doi.org/10.1016/S0731-7085(01)00553-2[Crossref]
• [23] D. Zendelovska, T. Stafilov and M. Stefova: “High-performance liquid chromatographic determination of diltiazem in human plasma after solid-phase and liquid-liquid extraction”, Anal. Bioanal. Chem., Vol. 376, (2003), pp. 848–853. http://dx.doi.org/10.1007/s00216-003-1996-9[Crossref]
• [24] R. Bindu and A.K. Chandrasekharan: “Colorimetric determination of diltiazem hydrochloride in pharmaceutical formulations”, Indian Drugs, Vol. 31, (1994), pp. 168–169.
• [25] M.M. Ayad, A. Shalaby, H.E. Abdellatef and M.M. Hosny: “New colorimetric method for the determination of trazodone HCl, famotidine and diltiazem HCl in their pharmaceutical dosage forms”, Anal. Bioanal. Chem., Vol. 376, (2003), pp. 710–714. http://dx.doi.org/10.1007/s00216-003-1954-6[Crossref]
• [26] B.V. Kamath and K. Shivram: “Extractive spectrophotometric method for the determination of diltiazem hydrochroide in its dosge forms”, Indian Drugs, Vol. 29, (1991), pp. 50–52.
• [27] D. Zivanov-Stakic, D. Agbaba, S. Vladimirov and L.J. Ciric: “Spectrophotometric determination of diltiazem in dosage forms”, Farmaco, Vol. 47, (1992), pp. 393–396.
• [28] Y.K. Agrawal, K. Shivramchanda and B.E. Rao: “Spectrophotometric methods for the determination of dilitiazem in pharmaceutical preparations”, Indian J. Pharm. Sci., Vol. 54, (1992), pp. 218–221.
• [29] B.V. Kamath, K. Shivram and A.C. Shah: “Selective spectrophotometric determination of diltiazem hydrochloride in tablets”, J. Pharm. Biomed. Anal., Vol. 11, (1993), pp. 407–409. http://dx.doi.org/10.1016/0731-7085(93)80037-2[Crossref]
• [30] K. Sreedhar, C.S.P. Sastry, M.N. Reddy and D.G. Sankar: “Extractive spectrophotometric determinations of diltiazem hydrochloride”, Indian Drugs, Vol. 32, (1995), pp. 90–92.
• [31] N. Rahman and S.N. Hejaz-Azmi: “Extractive spectrophotometric methods for determination of diltiazem HCl in pharmaceutical formulations using bromothymol blue, bromophenol blue and bromocresol green”, J. Pharm. Biomed. Anal., Vol. 24, (2000), pp. 33–41. http://dx.doi.org/10.1016/S0731-7085(00)00409-X[Crossref]
• [32] N. Rahman and S.N.H. Azmi: “Spectrophotometric determination of diltiazem hydrochloride with sodium metavanadate”, Microchem. J., Vol. 65, (2000), pp. 39–43. http://dx.doi.org/10.1016/S0026-265X(00)00025-4[Crossref]
• [33] V.V. Nalimov: The application of mathematical statistics to chemical analysis, Pergamon Press, Oxford, 1963.
• [34] J.C. Miller and J.N. Miller: “Significance tests”, In: Statistics for analytical chemistry, 3th ed., Ellis Horwood, Chichester, 1993.

Identifiers

DOI

10.2478/BF02479280